These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6580063

  • 1. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
    Dow LW, Sinkule JA, Look AT, Horvath A, Evans WE.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
    [Abstract] [Full Text] [Related]

  • 2. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
    Gupta RS, Singh B.
    J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC, Ross WE.
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [Abstract] [Full Text] [Related]

  • 4. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts.
    Kalwinsky DK, Look AT, Ducore J, Fridland A.
    Cancer Res; 1983 Apr; 43(4):1592-7. PubMed ID: 6572554
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.
    Pamidi CC, Derry WB, Gupta RS.
    Anticancer Drug Des; 1991 Nov; 6(5):481-93. PubMed ID: 1764166
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by 4'-demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) of human lymphoblast cultures in G2 phase of the cell cycle.
    Misra NC, Roberts DW.
    Cancer Res; 1975 Jan; 35(1):99-105. PubMed ID: 1053697
    [Abstract] [Full Text] [Related]

  • 7. Glycosylated podophyllotoxin congeners: loss of microtubule inhibition and permission of invasion in vitro.
    Mareel MM, Dragonetti CH, De Bruyne GK, Van Cauwenberge RM.
    J Natl Cancer Inst; 1982 Dec; 69(6):1367-74. PubMed ID: 6958912
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
    Loike JD, Brewer CF, Sternlicht H, Gensler WJ, Horwitz SB.
    Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
    [Abstract] [Full Text] [Related]

  • 9. 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.
    Rivera G, Avery T, Pratt C.
    Cancer Chemother Rep; 1975 Sep; 59(4):743-9. PubMed ID: 1100225
    [Abstract] [Full Text] [Related]

  • 10. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
    Kerrigan D, Pommier Y, Kohn KW.
    NCI Monogr; 1987 Sep; (4):117-21. PubMed ID: 3041238
    [Abstract] [Full Text] [Related]

  • 11. Predominant role for DNA damage in etoposide-induced cytotoxicity and cell cycle perturbation in human SV40-transformed fibroblasts.
    Smith PJ, Anderson CO, Watson JV.
    Cancer Res; 1986 Nov; 46(11):5641-5. PubMed ID: 3019531
    [Abstract] [Full Text] [Related]

  • 12. [Antitumor effect of etoposide and its analogs].
    Kuramochi H, Okamoto K, Nishikawa K, Nagamine S, Takahashi K.
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
    [Abstract] [Full Text] [Related]

  • 13. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
    Wozniak AJ, Ross WE.
    Cancer Res; 1983 Jan; 43(1):120-4. PubMed ID: 6847761
    [Abstract] [Full Text] [Related]

  • 14. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).
    Danks MK, Yalowich JC, Beck WT.
    Cancer Res; 1987 Mar 01; 47(5):1297-301. PubMed ID: 3469013
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities.
    Gupta RS, Chenchaiah PC, Gupta R.
    Anticancer Drug Des; 1987 Aug 01; 2(1):1-12. PubMed ID: 3449081
    [Abstract] [Full Text] [Related]

  • 16. Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
    Roberts D, Hilliard S, Peck C.
    Cancer Res; 1980 Nov 01; 40(11):4225-31. PubMed ID: 7471063
    [No Abstract] [Full Text] [Related]

  • 17. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1985 Jul 01; 45(7):3106-12. PubMed ID: 3839166
    [Abstract] [Full Text] [Related]

  • 18. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R.
    Klin Padiatr; 2002 Jul 01; 214(4):223-9. PubMed ID: 12165906
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ, Valeriote FA, Kalish R, Coulter D.
    Cancer Treat Rep; 1978 Sep 01; 62(9):1313-20. PubMed ID: 688275
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC, Hines LH, Rathmell JP.
    Cancer Res; 1985 Jul 01; 45(7):3070-5. PubMed ID: 4005845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.